|
|
BioGaia AB - Comparative Business Analysis Snapshot
Business Description
BioGaia AB. The Group's principal activities are the research, development and manufacturing of probiotic systems that build health in humans and animals. The products of the Group are based on the lactic acid bacterium Lactobacillus reuteri in combination with delivery systems that make it possible to create products with a long shelf life. Reuteri that has probiotic or health-enhancing effects occurs naturally in the intestinal flora of humans and animals. It inhibits the proliferation of harmful bacteria and promotes the growth of the normal intestinal microflora, thereby strengthening the immune system. The trademarks of the Group include Reuteri (R), LifeTop Straw and LifeTop Cap.
Competitor Analysis
This analysis compares BioGaia AB with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
